After decades of consolidation by Big Pharma, demand for modern lab and diagnostic space in New Jersey is on the rise, fueling rent growth and pushing some developers to consider new laboratory projects.
Thor Equities Group has landed a major tenant at its newly acquired life sciences campus in Bridgewater, inking a 101,500-square-foot lease with a biopharmaceutical company.
Thor Equities Group is eyeing plans to reposition a historic building in Jersey City into research and laboratory space, following its recent acquisition of the nearly 340,000-square-foot property.
